Neurocrine Biosciences, Inc. (NBIX)
NASDAQ·Healthcare·Biotechnology
$181.45
-0.75%
Mkt Cap $17.67B
Analyst Ratings
Buy
27
Hold
2
Sell
0
Price Target (69 analysts)
$188.62
Range $140.00 – $230.00
Implied Upside
+4.0%
Consensus $188.62 vs current $181.45